Immunoprecise Antibodies Ltd (IPA)

09:00 AM

Immunoprecise Antibodies discovers highly conserved epitope across all four dengue virus serotypes - BioWorld MedTech

09:00 AM

Jun 05, 2025

ImmunoPrecise Antibodies (IPA) Makes Breakthrough in Dengue Vacc - GuruFocus

Jun 05, 2025

Jun 05, 2025

ImmunoPrecise identifies universal dengue vaccine target By Investing.com - Investing.com Canada

Jun 05, 2025

Jun 05, 2025

Immunoprecise Announces Ai-Driven Breakthrough In Universal Dengue Vaccine Discovery - marketscreener.com

Jun 05, 2025

Jun 05, 2025

ImmunoPrecise Unveils AI-Driven Breakthrough in Dengue Vaccine Discovery - TipRanks

Jun 05, 2025

Jun 05, 2025

ImmunoPrecise identifies universal dengue vaccine target - Investing.com

Jun 05, 2025

Jun 05, 2025

ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery | IPA Stock News - GuruFocus

Jun 05, 2025

Jun 05, 2025

Revolutionary AI Platform Cracks Universal Dengue Vaccine Code After Decades of Failed Attempts - Stock Titan

Jun 05, 2025

May 24, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Stock Rating Upgraded by Wall Street Zen - Defense World

May 24, 2025

May 21, 2025

ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Eng - GuruFocus

May 21, 2025

May 21, 2025

ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts - Yahoo Finance

May 21, 2025

May 20, 2025

ImmunoPrecise Antibodies (IPA) to Present at Maxim Group's 2025 Virtual Tech Conference | IPA Stock News - GuruFocus

May 20, 2025

May 20, 2025

ImmunoPrecise Antibodies to Present at Maxim Group’s 2025 Virtual Tech Conference - TipRanks

May 20, 2025

May 20, 2025

AI Breakthrough: ImmunoPrecise CEO Reveals Next-Gen Biotherapeutics Strategy at Major Tech Conference - Stock Titan

May 20, 2025

May 20, 2025

ImmunoPrecise Antibodies (IPA) to Present at Maxim Group’s 2025 Virtual Tech Conference - New Castle News

May 20, 2025

May 20, 2025

What's Going on With Apple Stock? - The Globe and Mail

May 20, 2025

May 12, 2025

ImmunoPrecise Antibodies (IPA) Showcases Breakthrough in Epitope Mapping | IPA Stock News - GuruFocus

May 12, 2025

May 12, 2025

ImmunoPrecise Antibodies’ LENSai Platform Revolutionizes Epitope Mapping - TipRanks

May 12, 2025

May 12, 2025

IPA's LENSai™ Platform Delivers X-Ray--Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed | IPA Stock News - GuruFocus

May 12, 2025

May 12, 2025

IPA’s LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed - Yahoo Finance

May 12, 2025

May 04, 2025

ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Shares Leap 28% Yet They're Still Not Telling The Full Story - simplywall.st

May 04, 2025

Apr 25, 2025

How ImmunoPrecise Antibodies ($IPA) Uses AI to Transform Antibody-Based Drug Discovery - Podomatic

Apr 25, 2025

Apr 24, 2025

Views of Wall Street’s Leading Experts on ImmunoPrecise Antibodies Ltd - Sete News

Apr 24, 2025

Apr 24, 2025

ImmunoPrecise Antibodies (OTCMKTS:IPATF) Trading Down 7% – Should You Sell? - Defense World

Apr 24, 2025

Apr 23, 2025

What is going on with ImmunoPrecise Antibodies Ltd? Sentiment Analysis - uspostnews.com

Apr 23, 2025

Apr 22, 2025

Will ImmunoPrecise Antibodies (NASDAQ:IPA) Spend Its Cash Wisely? - simplywall.st

Apr 22, 2025

Apr 14, 2025

H.C. Wainwright sets $50 target for ImmunoPrecise stock - Investing.com Australia

Apr 14, 2025

Apr 14, 2025

H.C. Wainwright sets $50 target for ImmunoPrecise stock By Investing.com - Investing.com South Africa

Apr 14, 2025

Apr 14, 2025

ImmunoPrecise Antibodies’ (IPA) “Buy” Rating Reiterated at HC Wainwright - Defense World

Apr 14, 2025

Apr 12, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI- - GuruFocus

Apr 12, 2025

Apr 11, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods - 01net

Apr 11, 2025

Apr 11, 2025

ImmunoPrecise Antibodies Aligns with FDA’s Move to Non-Animal Testing - TipRanks

Apr 11, 2025

Apr 11, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSaitm with FDA's Shift to Non-Animal Testing Methods - Lelezard

Apr 11, 2025

Apr 11, 2025

AI Breakthrough: How IPA's LENSai Platform Leads FDA's Historic Shift from Animal Testing - Stock Titan

Apr 11, 2025

Apr 10, 2025

ImmunoPrecise Antibodies Partners with RIBOPRO to Enhance Antibody Discovery - TipRanks

Apr 10, 2025

Apr 04, 2025

HC Wainwright Has Positive Outlook of IPA FY2025 Earnings - Defense World

Apr 04, 2025

Apr 03, 2025

ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Apr 03, 2025

Apr 03, 2025

HC Wainwright Has Bearish Forecast for IPA FY2028 Earnings - Defense World

Apr 03, 2025

Apr 02, 2025

ImmunoPrecise Antibodies’ (IPA) “Speculative Buy” Rating Reaffirmed at Benchmark - Defense World

Apr 02, 2025

Apr 01, 2025

Benchmark maintains Speculative Buy on Immunoprecise stock By Investing.com - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

Benchmark maintains Speculative Buy on Immunoprecise stock - Investing.com

Apr 01, 2025

Apr 01, 2025

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2025 Earnings Call Transcript - Insider Monkey

Apr 01, 2025

Apr 01, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Price Target Lowered to $5.00 at HC Wainwright - Defense World

Apr 01, 2025

Mar 31, 2025

ImmunoPrecise Antibodies Earnings Call Highlights Growth - TipRanks

Mar 31, 2025

Mar 31, 2025

Immunoprecise stock target cut to $5 by H.C. Wainwright - Investing.com Australia

Mar 31, 2025